KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Other Non-Current Assets (2016 - 2025)

NovoCure (NVCR) has disclosed Other Non-Current Assets for 12 consecutive years, with $10.6 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 27.51% to $10.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.6 million through Dec 2025, down 27.51% year-over-year, with the annual reading at $10.6 million for FY2025, 27.51% down from the prior year.
  • Other Non-Current Assets hit $10.6 million in Q4 2025 for NovoCure, down from $12.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $15.6 million in Q2 2025 to a low of $10.6 million in Q4 2025.
  • Historically, Other Non-Current Assets has averaged $12.4 million across 5 years, with a median of $12.1 million in 2021.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 123.63% in 2021 and later fell 27.51% in 2025.
  • Year by year, Other Non-Current Assets stood at $12.1 million in 2021, then decreased by 7.65% to $11.2 million in 2022, then increased by 25.63% to $14.0 million in 2023, then rose by 4.25% to $14.6 million in 2024, then decreased by 27.51% to $10.6 million in 2025.
  • Business Quant data shows Other Non-Current Assets for NVCR at $10.6 million in Q4 2025, $12.4 million in Q3 2025, and $15.6 million in Q2 2025.